Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Waters

Showing results (191-200 of 1,025) with videos related to

Pageof 103
Sort By:
Circulation|January 1, 1992
Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusionY Taeymans, P Théroux, J Lespérance, et al.
Mutation Research|December 4, 2003
The impact of new technologies on human population studiesMichael D Waters, James K Selkirk, Kenneth Olden
Mutation Research|November 30, 1999
The Third International Conference on Environmental Mutagens in Human PopulationsW W Au, M Chulasiri, M D Waters
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 1, 1994
Development of a 10-day chorioallantoic membrane vascular assay as an alternative to the Draize rabbit eye irritation testD M Bagley, D Waters, B M Kong
Genetica|July 20, 2006
Absence of hypomethylation and LINE-1 amplification in a white x black rhinoceros hybridGauthier Dobigny, Paul D Waters, Terence J Robinson
Current Opinion in Lipidology|December 1, 1995
Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart diseaseG R Thompson, J Hollyer, D D Waters
The Canadian Journal of Cardiology|August 16, 2016
Performance Deficiencies in the Treatment of ST-Elevation Myocardial Infarction in Québec: "Tis But a Part We See, and Not a Whole"Rabih R Azar, Zena Kadri, David D Waters
Mutation Research|March 1, 1993
The genetic toxicology of putative nongenotoxic carcinogensM A Jackson, H F Stack, M D Waters
Vascular Health and Risk Management|June 18, 2015
Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in SingaporeSajita Setia, Selwyn Sze-Wang Fung, David D Waters
Mutation Research|August 17, 1996
Genetic activity profiles of anticancer drugsM A Jackson, H F Stack, M D Waters
Pageof 103

Showing results (191-200 of 1,025) with videos related to

Sort By:
Pageof 103
Circulation|January 1, 1992
Quantitative angiographic morphology of the coronary artery lesions at risk of thrombotic occlusionY Taeymans, P Théroux, J Lespérance, et al.
Mutation Research|December 4, 2003
The impact of new technologies on human population studiesMichael D Waters, James K Selkirk, Kenneth Olden
Mutation Research|November 30, 1999
The Third International Conference on Environmental Mutagens in Human PopulationsW W Au, M Chulasiri, M D Waters
Food and Chemical Toxicology : an International Journal Published for the British Industrial Biological Research Association|December 1, 1994
Development of a 10-day chorioallantoic membrane vascular assay as an alternative to the Draize rabbit eye irritation testD M Bagley, D Waters, B M Kong
Genetica|July 20, 2006
Absence of hypomethylation and LINE-1 amplification in a white x black rhinoceros hybridGauthier Dobigny, Paul D Waters, Terence J Robinson
Current Opinion in Lipidology|December 1, 1995
Percentage change rather than plasma level of LDL-cholesterol determines therapeutic response in coronary heart diseaseG R Thompson, J Hollyer, D D Waters
The Canadian Journal of Cardiology|August 16, 2016
Performance Deficiencies in the Treatment of ST-Elevation Myocardial Infarction in Québec: "Tis But a Part We See, and Not a Whole"Rabih R Azar, Zena Kadri, David D Waters
Mutation Research|March 1, 1993
The genetic toxicology of putative nongenotoxic carcinogensM A Jackson, H F Stack, M D Waters
Vascular Health and Risk Management|June 18, 2015
Doctors' knowledge, attitudes, and compliance with 2013 ACC/AHA guidelines for prevention of atherosclerotic cardiovascular disease in SingaporeSajita Setia, Selwyn Sze-Wang Fung, David D Waters
Mutation Research|August 17, 1996
Genetic activity profiles of anticancer drugsM A Jackson, H F Stack, M D Waters
Pageof 103